Cargando…
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis
The 2013–2016 Ebola virus (EBOV) epidemic in West Africa was unprecedented in case numbers and fatalities, and sporadic outbreaks continue to arise. Antibodies to the EBOV glycoprotein (GP) are strongly associated with survival and their use in immunotherapy is often initially based on their perform...
Autores principales: | Mellors, Jack, Tipton, Tom, Fehling, Sarah Katharina, Akoi Bore, Joseph, Koundouno, Fara Raymond, Hall, Yper, Hudson, Jacob, Alexander, Frances, Longet, Stephanie, Taylor, Stephen, Gorringe, Andrew, Magassouba, N’Faly, Konde, Mandy Kader, Hiscox, Julian, Strecker, Thomas, Carroll, Miles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039621/ https://www.ncbi.nlm.nih.gov/pubmed/35493467 http://dx.doi.org/10.3389/fimmu.2022.857481 |
Ejemplares similares
-
Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020) -
Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea
por: Longet, Stephanie, et al.
Publicado: (2023) -
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
por: Thom, Ruth, et al.
Publicado: (2020) -
Detection of Marburg Virus Disease in Guinea
por: Koundouno, Fara R., et al.
Publicado: (2022) -
Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins
por: Koch, Till, et al.
Publicado: (2020)